Figure 1 Time To 3-month Confirmed Disability Progression – Study 1 (itt Population) (Fingolimod 1)
Fingolimod Hydrochloride Capsule
Product Images NDC 16729-342
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fingolimod Hydrochloride (NDC 16729-342). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fingolimod Capsules 0.5 mg Label (Fingolimod Label)
Each capsule of this medication contains 0.56 mg of Fingolimod Hydrochloride, which is equivalent to 0.5 mg of Fingolimod. The recommended dosage is documented in the package insert. It must be stored in a cool and dry place within the temperature range of 20°C to 25°C (68°F to 77°F) with permissible excursions of 15°C to 30°C (59°F to 86°F) and must be protected from moisture. A medication guide is available for reference at DG 16729-342-10. The medication is available in the form of hard gelatin capsules from Accord Healthcare, Inc. The manufacturing plant is situated at Ahmedabad - 382210, India, by Intas Pharmaceuticals Limited. The lot and expiry date data is to be coated on the blank area. Pharmacists must dispense the medication with the enclosed medication guide.*
Fingolimod Chemical Structure (Fingolimod Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
